Interprofessional Simulation Program for Clinical Resilience and Empathy: Project INSPIRE (INSPIRE)
2026年8月5日 更新者:Melissa Watt、University of Utah
Interprofessional Simulation Program for Clinical Resilience and Empathy (INSPIRE) for Healthcare Teams Caring for Birthing Individuals With Substance Use Disorder in Utah
The goal of this clinical trial is to develop and evaluate INSPIRE, an intervention for healthcare teams to improve care for individuals with substance use disorder (SUD) during their peri-delivery care.
The main question it aims to answer is whether healthcare provider stigmas and behaviors change after receiving the training.
The study will be implemented at the University of Utah.
研究概览
详细说明
Individuals with substance use disorder (SUD) face a higher risk of severe maternal morbidity and mortality.
Provider stigma contribute to these outcomes by attenuating the provision of evidence-based, person-centered care.
The goal of this study is to evaluate INSPIRE, an intervention for interprofessional healthcare teams to improve care for individuals with substance use disorder (SUD) during their peri-delivery care.
INSPIRE includes three core modules (an online training on SUD in birth, an in-person simulation training, and an additional online training to assess and build clinical empathy skills).
The study team will evaluate INSPIRE at the University of Utah hospital using a quasi-experimental design to determine impact on healthcare team outcomes.
The study will enroll up to 300 healthcare team members across clinical specialties that support birthing individuals.
All enrolled providers will receive INSPIRE training, and assessments will be conducted at baseline, 1 month, 3 months, and 6 months.
The primary outcome for providers is stigma.
The study team will assess change in stigma scores from baseline to 6 months using a mixed effects linear regression model, specified to provide a paired-sample comparison between pre- and post-intervention scores.
研究类型
介入性
注册 (估计的)
300
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Assumpta Nantume
- 电话号码:801-585-6011
- 邮箱:assumpta.nantume@hsc.utah.edu
研究联系人备份
- 姓名:Erin Johnson
- 电话号码:801-646-7065
- 邮箱:erin.p.johnson@hsc.utah.edu
学习地点
-
-
Utah
-
Salt Lake City、Utah、美国、84102
- 招聘中
- University of Utah Health
-
接触:
- Assumpta Nantume
- 电话号码:801-585-6011
- 邮箱:assumpta.nantume@hsc.utah.edu
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Employed at the University of Utah Hospital
- Directly interfaces with birthing individuals (as clinical or non-clinical team member, e.g., physician, nurse, emergency medical technician, social worker)
- English speaking
Exclusion Criteria:
- Unable to provide informed consent
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:卫生服务研究
- 分配:不适用
- 介入模型:顺序分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:INSPIRE provider training
All providers will receive the INSPIRE intervention.
The INSPIRE intervention includes: 1) online learning modules #1, which is completed individually and should take approximately 2 hours, and 2) in-person simulation, which is done as a group and scheduled for 4 hours, and 3) online learning module #2.
|
The INSPIRE intervention includes: 1) online learning modules #1, which is completed individually and should take approximately 2 hours, and 2) in-person simulation, which is done as a group and scheduled for 4 hours, and 3) online learning module #2.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Medical Condition Regard Scale (MCRS)
大体时间:Administered at Baseline and 1 month, 3 months, and 6 months after Baseline
|
Medical Condition Regard Scale scores range from a minimum of 11 to a maximum of 66.
Higher scores mean a better outcome, representing a more positive attitude, higher regard, and greater willingness in treating or caring for a specific medical condition
|
Administered at Baseline and 1 month, 3 months, and 6 months after Baseline
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Melissa Watt, PhD、University of Utah
- 首席研究员:Susanna Cohen, DNP, CNM, CHSE, FAAN、University of Utah
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2026年8月1日
初级完成 (估计的)
2027年12月31日
研究完成 (估计的)
2027年12月31日
研究注册日期
首次提交
2026年7月10日
首先提交符合 QC 标准的
2026年7月10日
首次发布 (实际的)
2026年7月16日
研究记录更新
最后更新发布 (实际的)
2026年8月10日
上次提交的符合 QC 标准的更新
2026年8月5日
最后验证
2026年8月1日
更多信息
与本研究相关的术语
其他研究编号
- IRB_00167800
- U54HD113169 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
是的
IPD 计划说明
Deidentified data aligning with the Maternal Health Common Data Elements outlined by the IMPROVE Data Hub will be shared with the Maternal Health Data Innovation and Coordination Hub ("Data Hub").
The Data Hub will determine timing and methods of sharing gathered data from IMPROVE Centers and uploading congregated data into DASH.
IPD 共享时间框架
Supporting information will be shared with the Data Hub within 6 months of the completion of data collection, and available through DASH for as long as DASH maintains the data.
IPD 共享访问标准
All deidentified data and supporting information will be maintained by the DASH.
Access will be determined by the structures set forth by the Data Hub and DASH.
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.